Fox Corp
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: FOXA stock price vs LUMN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LUMN's multiple
Needs LUMN P/E.
Implied fair value · at FOXA's multiple
Needs Annual EPS is negative.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Fox Corp · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
LUMEN TECHNOLOGIES, INC. · implied price per share
Bear
-$11.13
Base
-$10.46
Bull
-$9.26
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe FOXA can sustain its 16.6% revenue growth and 14.1% net margin, then maintain or add to FOXA rather than anchor on the stated -53.4% implied downside, because the operating and valuation multiples in the comparison are materially stronger than LUMN's despite the inconsistent model output.
The stated valuation output implies FOXA would be worth $31.14 versus a current price of $66.81, or -53.4% downside, but that conclusion is difficult to reconcile with the rest of the data. On the provided multiples, FOXA appears cheaper and stronger than LUMN on earnings and cash-generation proxies, yet LUMN-implied valuation range is far below both FOXA's current price and the DCF range.
Supporting Metrics